NRG1 Regulation of Candida albicans Virulence

NRG1 白色念珠菌毒力的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Candida albicans is the most common etiological agent of candidiasis, now the fourth leading cause of nosocomial infections. C. albicans is able to undergo reversible morphological transitions between unicellular yeast-like forms (blastospore) and filamentous forms (called hypha or pseudohypha depending on slight variations in the structure of the filament). These morphogenetic conversions are pivotal to its pathogenic potential. This belief is based upon the results obtained from a large number of virulence studies using C. albicans mutant strains unable to undergo this morphogenetic switch (i.e. delta cph1, delta efg1, delta tup1). However, all these strains are locked in one or other form so conclusions on the role of the morphogenetic transitions in virulence cannot be adequately addressed. Also, these mutant strains have been constructed using the URA-blaster technique with inherent problems that place serious questions on the genetic homogeneity between parental and disrupted strains. To overcome these problems, we have constructed a C. albicans strain which in which we have placed the recently discovered NRG1 gene under the control of a tetracycline-regulatable promoter. In C. albicans, Nrg1p is a DNA-binding protein that functions as a negative regulator of filamentation. Experiments confirmed the ability of doxycycline (DOX) to control the morphological transitions in this strain under a number of laboratory conditions. This gene expression system has also the advantage that it can be used in an animal host where expression of the gene of interest is regulated by simply adding DOX to the drinking water. The specific aims of this proposal are: i) to use this strain in a murine model of candidiasis in order to assess the role of NRG1 and the morphogenetic conversions in C. albicans virulence and ii) to identify downstream targets of Nrg1p under both planktonic and biofilm growing conditions.
描述(由申请人提供):白色念珠菌是念珠菌病最常见的病原体,目前是医院感染的第四大原因。C.白色念珠菌能够在单细胞酵母样形式(芽生孢子)和丝状形式(根据丝状结构的轻微变化称为菌丝或假菌丝)之间进行可逆的形态转变。这些形态发生转换是其致病潜力的关键。这一观点是基于大量使用C.无法经历这种形态发生转换的白色念珠菌突变株(即delta cph 1、delta efg 1、delta tup 1)。然而,所有这些菌株都被锁定在一种或另一种形式中,因此无法充分说明形态发生转变在毒力中的作用。此外,这些突变株已经使用URA-爆破技术构建,其固有的问题对亲本和破坏株之间的遗传同质性提出了严重的问题。为了克服这些问题,我们构建了一个C。白念珠菌菌株,其中我们已经将最近发现的NRG 1基因置于四环素可调控启动子的控制下。In C. Nrg 1 p是一种DNA结合蛋白,其功能是作为表达的负调节因子。实验证实了多西环素(DOX)在许多实验室条件下控制该菌株形态转变的能力。该基因表达系统的优点还在于,它可以用于动物宿主,其中通过简单地将DOX加入到饮用水中来调节目的基因的表达。该建议的具体目的是:i)在念珠菌病的鼠模型中使用该菌株,以评估NRG 1的作用和在C.白色念珠菌毒力和ii)在增殖和生物膜生长条件下鉴定Nrg 1 p的下游靶标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jose L. Lopez-Ribot其他文献

Protocol optimization for a fast, simple and economical chemical reduction synthesis of antimicrobial silver nanoparticles in non-specialized facilities
  • DOI:
    10.1186/s13104-019-4813-z
  • 发表时间:
    2019-11-27
  • 期刊:
  • 影响因子:
    1.700
  • 作者:
    Roberto Vazquez-Muñoz;M. Josefina Arellano-Jimenez;Fernando D. Lopez;Jose L. Lopez-Ribot
  • 通讯作者:
    Jose L. Lopez-Ribot
Fungal biofilms in human health and disease
人类健康与疾病中的真菌生物膜
  • DOI:
    10.1038/s41579-025-01147-0
  • 发表时间:
    2025-02-05
  • 期刊:
  • 影响因子:
    103.300
  • 作者:
    Gordon Ramage;Ryan Kean;Riina Rautemaa-Richardson;Craig Williams;Jose L. Lopez-Ribot
  • 通讯作者:
    Jose L. Lopez-Ribot
Antifungal therapy of emCandida/em biofilms: Past, present and future
念珠菌生物膜的抗真菌治疗:过去、现在和未来
  • DOI:
    10.1016/j.bioflm.2023.100126
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    4.900
  • 作者:
    Olabayo H. Ajetunmobi;Hamid Badali;Jesus A. Romo;Gordon Ramage;Jose L. Lopez-Ribot
  • 通讯作者:
    Jose L. Lopez-Ribot

Jose L. Lopez-Ribot的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jose L. Lopez-Ribot', 18)}}的其他基金

BSL3 Drug Screening Core
BSL3 药物筛选核心
  • 批准号:
    10363478
  • 财政年份:
    2022
  • 资助金额:
    $ 7.3万
  • 项目类别:
BSL3 Drug Screening Core
BSL3 药物筛选核心
  • 批准号:
    10541228
  • 财政年份:
    2022
  • 资助金额:
    $ 7.3万
  • 项目类别:
High Throughput Screening of Medicines for Malaria Ventures Chemical Libraries to Identify Novel Inhibitors of Candida auris
疟疾药物的高通量筛选帮助化学库鉴定新型耳念珠菌抑制剂
  • 批准号:
    10383652
  • 财政年份:
    2021
  • 资助金额:
    $ 7.3万
  • 项目类别:
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates
筛选基于靶点的再利用文库的抗真菌病原体活性以及主要候选药物的后续临床前开发
  • 批准号:
    10320258
  • 财政年份:
    2019
  • 资助金额:
    $ 7.3万
  • 项目类别:
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates
筛选基于靶点的再利用文库的抗真菌病原体活性以及主要候选药物的后续临床前开发
  • 批准号:
    10335279
  • 财政年份:
    2019
  • 资助金额:
    $ 7.3万
  • 项目类别:
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates
筛选基于靶点的再利用文库的抗真菌病原体活性以及主要候选药物的后续临床前开发
  • 批准号:
    10544529
  • 财政年份:
    2019
  • 资助金额:
    $ 7.3万
  • 项目类别:
Development of novel chemical series of Candida albicans biofilm inhibitors
白色念珠菌生物膜抑制剂新型化学系列的开发
  • 批准号:
    8951343
  • 财政年份:
    2015
  • 资助金额:
    $ 7.3万
  • 项目类别:
Development of Monoclonal Antibody (Mab) Biologics against Neonatal Candidiasis
抗新生儿念珠菌病单克隆抗体 (Mab) 生物制剂的开发
  • 批准号:
    8425740
  • 财政年份:
    2013
  • 资助金额:
    $ 7.3万
  • 项目类别:
Development of Monoclonal Antibody (Mab) Biologics against Neonatal Candidiasis
抗新生儿念珠菌病单克隆抗体 (Mab) 生物制剂的开发
  • 批准号:
    8719015
  • 财政年份:
    2013
  • 资助金额:
    $ 7.3万
  • 项目类别:
Targeting virulence against oral candidiasis in HIV/AIDS
针对艾滋病毒/艾滋病口腔念珠菌病的毒力
  • 批准号:
    9234520
  • 财政年份:
    2013
  • 资助金额:
    $ 7.3万
  • 项目类别:

相似海外基金

Targeting pathogenic TAR DNA-binding protein 43 to treat frontotemporal dementia and motor neuron disease
靶向致病性 TAR DNA 结合蛋白 43 治疗额颞叶痴呆和运动神经元疾病
  • 批准号:
    nhmrc : 2001572
  • 财政年份:
    2021
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Ideas Grants
Electron microscopic analysis of a G4 DNA-binding protein Rif1, a key organizer of chromosomal domains
G4 DNA 结合蛋白 Rif1(染色体结构域的关键组织者)的电子显微镜分析
  • 批准号:
    18K06102
  • 财政年份:
    2018
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of methylated DNA-binding protein CIBZ in mouse embryogenesis
甲基化DNA结合蛋白CIBZ在小鼠胚胎发生中的功能分析
  • 批准号:
    16K08587
  • 财政年份:
    2016
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Continuous directed evolution of a light-controlled DNA-binding protein
光控DNA结合蛋白的连续定向进化
  • 批准号:
    437922-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Function and evolution of mitochondrial DNA-binding protein in the fission yeast
裂殖酵母线粒体DNA结合蛋白的功能和进化
  • 批准号:
    15K07168
  • 财政年份:
    2015
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a photo-controlled DNA-binding protein
光控 DNA 结合蛋白的开发
  • 批准号:
    459937-2014
  • 财政年份:
    2015
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Functional analysis of the single-stranded DNA-binding protein FUBP1 as a transcriptional regulator of hematopoietic stem cell self-renewal
单链DNA结合蛋白FUBP1作为造血干细胞自我更新转录调节因子的功能分析
  • 批准号:
    276833671
  • 财政年份:
    2015
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Research Grants
Continuous directed evolution of a light-controlled DNA-binding protein
光控DNA结合蛋白的连续定向进化
  • 批准号:
    437922-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Structural ans functional analysis of single-stranded DNA-binding protein DdrA
单链 DNA 结合蛋白 DdrA 的结构和功能分析
  • 批准号:
    26506030
  • 财政年份:
    2014
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a photo-controlled DNA-binding protein
光控 DNA 结合蛋白的开发
  • 批准号:
    459937-2014
  • 财政年份:
    2014
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了